Esperion Therapeutics, Inc.
ESPRNASDAQHealthcare● Active
$3.15
+$0.02(+0.64%)
Market Cap$654912465
P/E Ratio—
52W High$4.18
52W Low$0.95
Esperion Therapeutics, Inc.（ESPR）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ESPR · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.17B | $0.14B | $0.08B | $0.17B | $0.26B |
| Net Receivables | $0.14B | $0.08B | $0.05B | $0.03B | $0.02B |
| Inventory | $0.11B | $0.09B | $0.07B | $0.04B | $0.03B |
| Total Current Assets | $0.17B | $0.34B | $0.20B | $0.25B | $0.33B |
| PP&E Net | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.47B | $0.34B | $0.21B | $0.25B | $0.38B |
| Liabilities | |||||
| Short-Term Debt | $0.09B | $0.10B | $0.03B | $0.00B | $0.00B |
| Accounts Payable | $0.07B | $0.05B | $0.03B | $0.02B | $0.02B |
| Total Current Liabilities | $0.30B | $0.25B | $0.16B | $0.09B | $0.07B |
| Long-Term Debt | $0.46B | $0.48B | $0.50B | $0.26B | $0.26B |
| Total Liabilities | $0.77B | $0.73B | $0.66B | $0.57B | $0.58B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.62B) | ($1.60B) | ($1.55B) | ($1.34B) | ($1.11B) |
| Total Stockholders Equity | ($0.30B) | ($0.39B) | ($0.45B) | ($0.32B) | ($0.20B) |
| Total Liab & Equity(computed) | $0.47B | $0.34B | $0.21B | $0.25B | $0.38B |
| Debt Summary | |||||
| Total Debt | $0.55B | $0.59B | $0.54B | $0.26B | $0.26B |
| Net Debt | $0.38B | $0.45B | $0.46B | $0.14B | $0.05B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Esperion Therapeutics, Inc.
关于Esperion Therapeutics, Inc.（ESPR）资产负债表
Esperion Therapeutics, Inc.总资产$0.47B，现金及短期投资$0.17B，总负债$0.77B，总债务$0.55B，股东权益($0.30B)。
常见问题
ESPR · 4 问Esperion Therapeutics, Inc.总债务$0.55B，净债务$0.38B。
ESPR total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10